Moderna, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeSep 30 →InsidersNo open-market buys. 4 insiders sold $15.5M, 7 of 9 sales on a 10b5-1 plan.→HoldersFMR 13.0%BlackRock 7.7%Vanguard 5.8%→Financing →PeersClosest companies: KRRO, CTMX, DSGN→
From the filings
Figures
- Revenue
- $2.23Blast 12 months
- Net income
- −$3.15Blast 12 months
- Operating cash flow
- −$1.47Blast 12 months
- Cash and equivalents
- $1.72Bat the last balance sheet
- Total debt
- $591.0Mat the last balance sheet
- Shares outstanding
- 399.0M shareson issue